Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Some 14% of global prevalence, based on high-income country populations, suffers from migraine. Chronic migraine is very disabling, being characterized by at least 15 headache days per month of which at least 8 days present the features of migraine. Onabotulinumtoxin A, targeting the machinery for e...

Descripción completa

Detalles Bibliográficos
Autores principales: Corasaniti, Maria Tiziana, Bagetta, Giacinto, Nicotera, Pierluigi, Tarsitano, Assunta, Tonin, Paolo, Sandrini, Giorgio, Lawrence, Gary W., Scuteri, Damiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223125/
https://www.ncbi.nlm.nih.gov/pubmed/37235366
http://dx.doi.org/10.3390/toxins15050332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223125/
https://www.ncbi.nlm.nih.gov/pubmed/37235366
http://dx.doi.org/10.3390/toxins15050332

Ejemplares similares